Romidepsin
Back to searchMolecule Structure
Scientific Name
Romidepsin
Description of the Drug
Romidepsin is a histone deacetylase (HDAC) inhibitor used to treat cutaneous T-cell lymphoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06176
http://www.drugbank.ca/drugs/DB06176
Brand Name(s)
Chromadax, Istodax
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Celgene Corp, Fresenius Kabi Usa Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histone deacetylase | PROTEIN FAMILY | INHIBITOR | CHEMBL2093865 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL677497 | |||
PharmGKB | PA166161306 | |||
DrugBank | DB06176 | |||
PubChem: Thomson Pharma | 14763478 | 14763476 | ||
PubChem | 5352062 | |||
LINCS | LSM-45396 | |||
BindingDB | 19151 | |||
DrugCentral | 4119 | |||
Brenda | 151859 | 139218 | 39093 | 75548 |
Guide to Pharmacology | 7006 | |||
rxnorm | ROMIDEPSIN | ISTODAX | ||
PubChem: Drugs of the Future | 12014448 | |||
ChEBI | 61080 | |||
ZINC | ZINC000003935130 |